The Use of Continuous Glucose Monitors for Preoperative Monitoring and Treatment of Hypoglycemia in Patients Diagnosed With Pancreatic Neuroendocrine Tumors: A Case Report

AACE Clinical Case Reports
doi 10.4158/accr-2018-0590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AACE Corp (American Association of Clinical Endocrinologists)

Related search

Use of Continuous Glucose Monitoring in the Detection and Prevention of Hypoglycemia

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2007English

Medical Treatment of Neuroendocrine Gut and Pancreatic Tumors

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Preoperative Glucose Abnormalities in Patients With Pancreatic Tumours

Przeglad Gastroenterologiczny
Gastroenterology
2014English

Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case

Medical Council
2019English

Nocturnal Hypoglycemia Identified by a Continuous Glucose Monitoring System in Patients With Primary Adrenal Insufficiency (Addison's Disease)

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2012English

Combined Treatment of Patients With Pancreatic Neuroendocrine Carcinomas

Annals of HPB Surgery
HepatologySurgeryGastroenterology
2018English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Promising Developments for Pancreatic Neuroendocrine Tumors

Cancer Discovery
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy